Triquera Partners with Admaius in Strategic Investment in Minapharm
Deal News | Jul 29, 2025 | Legal Community MENA
Matouk Bassiouny & Hennawy (MBH) has advised Triquera, the majority shareholder of Minapharm Pharmaceuticals, in a strategic deal where Admaius Capital Partners, a private equity firm focused on Africa, acquired a minority stake in Minapharm. This partnership aims to enhance the development and manufacturing of complex genetically engineered therapies, as well as extend their distribution networks across Africa and the Middle East. The investment was completed through Admaius's investment vehicle, Virunga Healix Limited, marking a significant collaboration between the two firms to drive innovation in the pharmaceutical sector.
Sectors
- Pharmaceuticals
- Private Equity
Geography
- Africa – The investment and strategic partnership aim to enhance pharmaceutical development and distribution across the African continent.
- Middle East – The distribution network expansion includes the Middle East, highlighting the geographical scope of the strategic partnership.
Industry
- Pharmaceuticals – The investment in Minapharm Pharmaceuticals focuses on developing and manufacturing complex genetically engineered therapies.
- Private Equity – Admaius Capital Partners, a private equity firm, has invested in Minapharm Pharmaceuticals, demonstrating the role of private equity in strategic industry partnerships.
Financials
- Not Specified – The specific financial terms of the minority stake investment were not disclosed.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Matouk Bassiouny & Hennawy (MBH) | Legal Advisor | Company | Advised Triquera in the investment transaction. |
| Triquera | Majority Shareholder | Company | Majority shareholder of Minapharm Pharmaceuticals partnering with Admaius. |
| Minapharm Pharmaceuticals | Target Company | Company | Pharmaceutical company receiving investment for development and distribution expansion. |
| Admaius Capital Partners | Investor | Company | Private equity firm investing in Minapharm Pharmaceuticals. |
| Virunga Healix Limited | Investment Vehicle | Company | Admaius Capital Partners' investment vehicle for the transaction. |